Guardian Pharmacy Services, Inc.GRDNEarnings & Financial Report
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
GRDN Q1 FY2026 Key Financial Metrics
Revenue
$336.6M
Gross Profit
$76.3M
Operating Profit
$17.7M
Net Profit
$13.5M
Gross Margin
22.7%
Operating Margin
5.3%
Net Margin
4.0%
YoY Growth
2.2%
EPS
$0.21
Guardian Pharmacy Services, Inc. Q1 FY2026 Financial Summary
Guardian Pharmacy Services, Inc. reported revenue of $336.6M (up 2.2% YoY) for Q1 FY2026, with a net profit of $13.5M (up 46.1% YoY) (4.0% margin). Cost of goods sold was $260.3M, operating expenses totaled $58.6M.
Key Financial Metrics
| Total Revenue | $336.6M |
|---|---|
| Net Profit | $13.5M |
| Gross Margin | 22.7% |
| Operating Margin | 5.3% |
| Report Period | Q1 FY2026 |
Guardian Pharmacy Services, Inc. Annual Revenue by Year
Guardian Pharmacy Services, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4B).
Guardian Pharmacy Services, Inc. Quarterly Revenue & Net Profit History
Guardian Pharmacy Services, Inc. results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $336.6M | +2.2% | $13.5M | 4.0% |
| Q4 FY2025 | $397.6M | — | $20.9M | 5.3% |
| Q3 FY2025 | $377.4M | +20.0% | $9.8M | 2.6% |
| Q2 FY2025 | $344.3M | — | $9.0M | 2.6% |
| Q1 FY2025 | $329.3M | — | $9.4M | 2.9% |
| Q3 FY2024 | $314.4M | — | $-122.0M | -38.8% |
Income Statement
| Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $314.4M | $329.3M | $344.3M | $377.4M | $397.6M | $336.6M |
| YoY Growth | N/A | N/A | N/A | 20.0% | N/A | 2.2% |
Balance Sheet
| Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|
| Assets | $348.0M | $334.0M | $356.3M | $390.0M | $412.7M | $426.9M |
| Liabilities | $214.1M | $170.8M | $176.7M | $194.5M | $194.7M | $194.5M |
| Equity | $133.9M | $163.2M | $179.7M | $195.5M | $217.9M | $232.4M |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|
| Operating CF | $17.6M | $19.9M | $28.2M | $34.6M | $6.1M |